Over-expression of AXL has been shown to be involved in the stabilization and increased protein level of β-catenin in CML which is confirmed by the up-regulation of β-catenin target genes. This evidence concerns the gene AXL and chronic myelogenous leukemia, BCR-ABL1 positive.